Macropinocytosis: A central orchestrator in tumor development and therapeutic resistance
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-09 · 1881 (4) · 189655
DOI: 10.1016/j.bbcan.2026.189655 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-09. Verfasst von Chuxiang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China. Hauptthemen laut MEDLINE: Pinocytosis, Drug Resistance, Neoplasm, Neoplasms. Die Arbeit nennt 155 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Macropinocytosis, a dysregulated endocytic pathway prevalent in cancers, drives tumor progression by scavenging extracellular nutrients and activating oncogenic signaling. This review proposed a functional categorization of macropinocytosis based on the basal activity and stimulus origin. We then delineated the specific signaling networks governing this process and its cell type-specific functions within the tumor microenvironment, which collectively fuel malignant phenotypes and modulate diverse cell death modalities, including ferroptosis, cuproptosis, and alkaliptosis. Furthermore, we critically evaluated the therapeutic potential of targeting macropinocytosis in oncology, highlighting synergistic combination strategies and outlining key future directions such as the identification of specific biomarkers, exploration of non-canonical functions, and elucidation of its role in intercellular communication. This synthesis reframes macropinocytosis from a mere metabolic adaptation to a central orchestrator of tumor biology, thereby providing a robust rationale for its therapeutic inhibition in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, Chin…
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electron…
- Institute of Cancer Research, Henan Academy of Innovations in Medical Science, Zhengzhou 451162, China. Electronic address: jhyuan1998@163.com.
Förderung
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- National Natural Science Foundation of China
Zitieren
APA
Wang, C., Wang, X., Jiang, Z., Zhao, J., Wang, X., Liu, Y., Yuan, J., & Jiao, Y. (2026). Macropinocytosis: A central orchestrator in tumor development and therapeutic resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(4), 189655. https://doi.org/10.1016/j.bbcan.2026.189655
Vancouver
Wang C, Wang X, Jiang Z, Zhao J, Wang X, Liu Y, et al. Macropinocytosis: A central orchestrator in tumor development and therapeutic resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(4):189655. doi:10.1016/j.bbcan.2026.189655
BibTeX
@article{Wang2026,
author = {Wang, Chuxiang and Wang, Xin and Jiang, Ziyi and Zhao, Junyi and Wang, Xiaobing and Liu, Yutao and Yuan, Junhu and Jiao, Yuchen},
title = {Macropinocytosis: A central orchestrator in tumor development and therapeutic resistance},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {4},
pages = {189655},
doi = {10.1016/j.bbcan.2026.189655}
}
EUVIMED